| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $54.9K | +3.55K | +0.5% | $15.46* | 719K | May 6, 2021 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$482K | -3.55K | -0.49% | $135.75 | 715K | May 6, 2021 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $280K | +18.1K | +2.53% | $15.46* | 733K | May 6, 2021 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$2.44M | -18.1K | -2.47% | $135.11 | 715K | May 6, 2021 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $119K | +7.72K | +1.08% | $15.46* | 723K | May 6, 2021 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$1.04M | -7.72K | -1.07% | $134.29 | 715K | May 6, 2021 | Direct | F1, F2, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3.55K | -3.02% | $0.00 | 114K | May 6, 2021 | Common Stock | 3.55K | $15.46 | Direct | F6 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -18.1K | -15.88% | $0.00 | 95.8K | May 6, 2021 | Common Stock | 18.1K | $15.46 | Direct | F6 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -7.72K | -8.06% | $0.00 | 88.1K | May 6, 2021 | Common Stock | 7.72K | $15.46 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $135.63 to $135.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $134.63 to $135.62. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $133.63 to $134.62. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Options vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/24/15. |